News
The Sabin Vaccine Institute has launched a multi-site Phase 2 clinical trial in the U.S. for its Marburg vaccine candidate, ...
On January 20, Tanzania declared an outbreak of Marburg virus disease, which ended on March 13. For the U.S. clinical trial that began this week, Sabin will recruit 200 volunteers aged 18 to 70 across ...
The Sabin Vaccine Institute has launched a multi-site Phase 2 clinical trial in the U.S. for its Marburg vaccine candidate, administering doses to the ...
2d
The Citizen on MSNWHO member states reach agreement to tackle future pandemicsMembers of the World Health Organization reached an agreement to prepare the world for future pandemics after more than three ...
1d
Clinical Trials Arena on MSNSabin Vaccine Institute begins trial of vaccine candidate for Marburg virus diseaseThe Sabin Vaccine Institute has begun a Phase II trial in the US to evaluate its Marburg vaccine, with the first doses being ...
17h
News-Medical.Net on MSNAfrica CDC and WHO strengthen mpox response with updated strategyAfrica CDC and WHO have updated their joint Continental Response Plan for the mpox emergency as the disease continues to affect new areas.
The global outbreak of mpox in 2022–23 affected more than 100 countries and grabbed the attention of the scientific community ...
Marburg virus belongs to the genus Marburgvirus in the family Filoviridae and causes a severe hemorrhagic fever, known as Marburg hemorrhagic fever (MHF), in both humans and nonhuman primates.
The research reveals ... Nasal Spray H5N1 Avian Influenza Vaccine Developed Apr. 8, 2025 — Scientists have pioneered an influenza virus vector-based nasal spray vaccine platform and developed a ...
As well as providing the standard anti-virus protection, the Avira Free security suite also provides a software updater, as well as scanning your network for vulnerabilities and helps you fix them.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results